Expert Recap

Metastatic Breast Cancer: A Clinical Update

Source: Metastatic Breast Cancer*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Metastatic Breast Cancer: A Clinical Update

Faculty:
Clifford A. Hudis, MD

CME CREDIT INFORMATION

Release Date: 02/12/07

Expiration Date: 02/11/08

Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the results of recent studies evaluating the use of trastuzumab combination therapy for the treatment of metastatic breast cancer
Recall studies that investigated the use of albumin-bound paclitaxel in the first-line treatment of metastatic breast cancer
Discuss the therapeutic management of treatment-experienced patients with metastatic breast cancer

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.